Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 6415  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective study

Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah H, Tripathi C

Year : 2011| Volume: 57| Issue : 2 | Page no: 115-119

   This article has been cited by
 
1 Cefixime induced Steven Johnson syndrome: A case report from Bangladesh
Abhigan Babu Shrestha, Sajina Shrestha, Prashant Kumar Yadav, Lukash Adhikari, Anuj Yadav
Annals of Medicine and Surgery. 2022; : 104089
[Pubmed]  [Google Scholar] [DOI]
2 Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature
Hanne Sommerfelt, Lene F. Sandvik, Ingeborg M. Bachmann, Ragnvald Ljones Brekke, Henrik Løvendahl Svendsen, Anne Berit Guttormsen, Sura Aziz, Hanna Dillekås, Oddbjørn Straume
Acta Oncologica. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Clinical and Epidemiological Features of Patients with Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Iran: Different Points of Children from Adults
Bahareh Abtahi-Naeini, Mohammad-sadegh Dehghan, Fatemeh Paknazar, Zabihollah Shahmoradi, Gita Faghihi, Ali Mohammad Sabzghabaee, Mojtaba Akbari, Mahdi Hadian, Tooba Momen, Samuel Menahem
International Journal of Pediatrics. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
4 Capecitabine induced Steven–Johnson syndrome: A rare case report
Kavya Karthikeyan, Sameera K V, Shintu Shaji, Swetha M Ann C, Madhu C S
Journal of Oncology Pharmacy Practice. 2021; : 1078155221
[Pubmed]  [Google Scholar] [DOI]
5 A Systematic Review of Efficacy and Safety of Monotherapy and Combination Therapy With Biologic for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Muskaan Sachdeva, Khalad Maliyar, Marisa G. Ponzo
Journal of Cutaneous Medicine and Surgery. 2021; : 1203475421
[Pubmed]  [Google Scholar] [DOI]
6 The Profiles of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Patients in Tertiary Hospital
William Andrew Isaac, Damayanti Damayanti, Nurmawati Fatimah, Afif Nurul Hidayati
Berkala Ilmu Kesehatan Kulit dan Kelamin. 2021; 33(2): 116
[Pubmed]  [Google Scholar] [DOI]
7 Rifampicin- and allopurinol-induced Stevens-Johnson syndrome: A case series
Bhavana Srivastava, Reena Bhardwaj, Renu Khanchandani, Zafar Masood Ansari, Gunjita Belwal
Indian Journal of Physiology and Pharmacology. 2021; 65: 51
[Pubmed]  [Google Scholar] [DOI]
8 HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
Patompong Satapornpong, Jirawat Pratoomwun, Pawinee Rerknimitr, Jettanong Klaewsongkram, Nontaya Nakkam, Thanyada Rungrotmongkol, Parinya Konyoung, Niwat Saksit, Ajanee Mahakkanukrauh, Warayuwadee Amornpinyo, Usanee Khunarkornsiri, Therdpong Tempark, Kittipong Wantavornprasert, Pimonpan Jinda, Napatrupron Koomdee, Thawinee Jantararoungtong, Ticha Rerkpattanapipat, Chuang-Wei Wang, Dean Naisbitt, Wichittra Tassaneeyakul, Manasalak Ariyachaipanich, Thapana Roonghiranwat, Munir Pirmohamed, Wen-Hung Chung, Chonlaphat Sukasem
Frontiers in Immunology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
9 Drug-related Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review
Vivek Gupta, Shikha Panwar, Rajesh K Pande, Rohini Arora
Indian Journal of Critical Care Medicine. 2021; 25(5): 575
[Pubmed]  [Google Scholar] [DOI]
10 Severe cutaneous adverse reaction associated with antiseizure medications: Diagnosis, management, and prevention
Christian Brandt, Lynanne McGuire, Jack Uetrecht
Epilepsy & Behavior. 2021; 117: 107844
[Pubmed]  [Google Scholar] [DOI]
11 Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center
Kristyna L. Gleghorn, Charles Voigt, Brent Kelly
Pediatric Dermatology. 2021; 38(4): 812
[Pubmed]  [Google Scholar] [DOI]
12 Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance database
Jianhong Zhu, Guanghui Chen, Zhichao He, Yayuan Zheng, Siyuan Gao, Jianfang Li, Yin Ling, Xiaoxia Yu, Kaifeng Qiu, Junyan Wu
EClinicalMedicine. 2021; 37: 100951
[Pubmed]  [Google Scholar] [DOI]
13 Hypersensitivity Reactions to Non-Beta Lactam Antibiotics
Asli Gelincik, Semra Demir
Current Treatment Options in Allergy. 2021; 8(3): 161
[Pubmed]  [Google Scholar] [DOI]
14 Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
Connie Qiu, Alina Shevchenko, Sylvia Hsu
JAAD Case Reports. 2020; 6(5): 400
[Pubmed]  [Google Scholar] [DOI]
15 Lamotrigine induced toxic epidermal necrolysis: A case report
Kiran Kumar KC, Trishant Limbu, Shirish Shakti Maskay, Anil Bhasima, Subhash Prasad Acharya
Annals of Medicine and Surgery. 2020; 60: 468
[Pubmed]  [Google Scholar] [DOI]
16 Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis
I. Torres-Navarro, Á. Briz-Redón, R. Botella-Estrada
Journal of the European Academy of Dermatology and Venereology. 2020; 34(9): 2066
[Pubmed]  [Google Scholar] [DOI]
17 The psychological impact of Stevens–Johnson syndrome and toxic epidermal necrolysis on patients’ lives: a Critically Appraised Topic*
P. O'Reilly, C. Kennedy, P. Meskell, A. Coffey, I. Delaunois, L. Dore, S. Howard, B. Ramsay, C. Scanlon, D.M. Wilson, B. Whelan, S. Ryan
British Journal of Dermatology. 2020; 183(3): 452
[Pubmed]  [Google Scholar] [DOI]
18 Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics
Patompong Satapornpong, Pimonpan Jinda, Thawinee Jantararoungtong, Napatrupron Koomdee, Chonlawat Chaichan, Jirawat Pratoomwun, Chalitpon Na Nakorn, Wichai Aekplakorn, Alisa Wilantho, Chumpol Ngamphiw, Sissades Tongsima, Chonlaphat Sukasem
Frontiers in Pharmacology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
19 Epidemiology and Risk Factors for Severe Delayed Drug Hypersensitivity Reactions
Eva S.R. Gomes, Maria L. Marques, Frederico S. Regateiro
Current Pharmaceutical Design. 2019; 25(36): 3799
[Pubmed]  [Google Scholar] [DOI]
20 Cutaneous Adverse Effects of Neurologic Medications
Eman Bahrani, Chloe E. Nunneley, Sylvia Hsu, Joseph S. Kass
CNS Drugs. 2016; 30(3): 245
[Pubmed]  [Google Scholar] [DOI]
21 Toxicodermias graves: ¿existen las formas combinadas?
C. Horcajada-Reales,A. Pulido-Pérez,R. Suárez-Fernández
Actas Dermo-Sifiliográficas. 2016; 107(1): 23
[Pubmed]  [Google Scholar] [DOI]
22 Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
C. Horcajada-Reales,A. Pulido-Pérez,R. Suárez-Fernández
Actas Dermo-Sifiliográficas (English Edition). 2016; 107(1): 23
[Pubmed]  [Google Scholar] [DOI]
23 Pediatric Toxic Epidermal Necrolysis
Anna Beck,Kevin P. Quirke,Richard L. Gamelli,Michael J. Mosier
Journal of Burn Care & Research. 2015; 36(1): 167
[Pubmed]  [Google Scholar] [DOI]
24 A 15-Year Review of Pediatric Toxic Epidermal Necrolysis
Kevin P. Quirke,Anna Beck,Richard L. Gamelli,Michael J. Mosier
Journal of Burn Care & Research. 2015; 36(1): 130
[Pubmed]  [Google Scholar] [DOI]
25 Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions
Thachanan Kongpan,Surakameth Mahasirimongkol,Parinya Konyoung,Sirimas Kanjanawart,Pansu Chumworathayi,Nuanjun Wichukchinda,Runglak Kidkeukarun,Suphanlinee Preechakul,Usanee Khunarkornsiri,Warawut Bamrungram,Butsaban Supharatwattanakun,Piroon Mootsikapun,Supanida Kwangsukstid,Sukanda Denjanta,Suda Vannaprasaht,Watcharee Rungapiromnan,Wimon Suwankesawong,Wongwiwat Tassaneeyakul,Wichittra Tassaneeyakul
Pharmacogenetics and Genomics. 2015; 25(8): 402
[Pubmed]  [Google Scholar] [DOI]
26 Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study
I.M.M.H. Oen,C.H. van der Vlies,Y.W.F. Roeleveld,J. Dokter,M.J. Hop,M.E. van Baar
Journal of the European Academy of Dermatology and Venereology. 2015; 29(12): 2444
[Pubmed]  [Google Scholar] [DOI]
27 Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review
Julie A. Yager
Veterinary Dermatology. 2014; 25(5): 406
[Pubmed]  [Google Scholar] [DOI]
28 Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience
Jovan Lalosevic,Milos Nikolic,Mirjana Gajic-Veljic,Dusan Skiljevic,Ljiljana Medenica
International Journal of Dermatology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
29 Signal detection for Thai traditional medicine: Examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk
Sareeya Wechwithan,Wimon Suwankesawong,Vorasith Sornsrivichai,Edward B. McNeil,Chuleeporn Jiraphongsa,Virasakdi Chongsuvivatwong
Regulatory Toxicology and Pharmacology. 2014; 70(1): 407
[Pubmed]  [Google Scholar] [DOI]
30 Analysis of Drugs Causing Severe Cutaneous Adverse Reactions, Based on the Korean Database of Spontaneously Reported Adverse Drug Reactions
Mi-Yeong Kim,Min-Suk Yang,Hye-Ryun Kang,Sang-Heon Cho,Kyung-Up Min
Korean Journal of Medicine. 2014; 86(6): 710
[Pubmed]  [Google Scholar] [DOI]
31 Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital, Navamindradhiraj University, Bangkok
Wanjarus Roongpisuthipong,Sirikarn Prompongsa,Theerawut Klangjareonchai
Dermatology Research and Practice. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
32 Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen
Eun-Jin Kim,Hyun Lim,So Young Park,Sujeong Kim,Sun-Young Yoon,Yun-Jeong Bae,Hyouk-Soo Kwon,You Sook Cho,Hee-Bom Moon,Tae-Bum Kim
Asia Pacific Allergy. 2013; 4(1): 68
[Pubmed]  [Google Scholar] [DOI]
33 Drug-Induced Rash: Nuisance or Threat?
Jeannette Y. Wick
The Consultant Pharmacist. 2013; 28(3): 160
[Pubmed]  [Google Scholar] [DOI]
34 Stevens–Johnson Syndrome and HIV in Children in Swaziland
Eric J. Dziuban,Allison B. Hughey,David A. Stewart,Douglas A. Blank,Duncan Kochelani,Heather R. Draper,Gordon E. Schutze
The Pediatric Infectious Disease Journal. 2013; 32(12): 1354
[Pubmed]  [Google Scholar] [DOI]
35 Dermatological manifestations and relationship to outcomes of patients admitted to a medical intensive care unit: a study from a tertiary care hospital in India
P. Agrawal,J. V. Peter,R. George
Postgraduate Medical Journal. 2013; 89(1055): 501
[Pubmed]  [Google Scholar] [DOI]
36 Rapidly Developing Toxic Epidermal Necrolysis
Viktoria Oline Barrios Poulsen,Jonas Nielsen,Troels Dirch Poulsen
Case Reports in Emergency Medicine. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
37 Stevens-Johnson syndrome and toxic epidermal necrolysis in children
Marina Atanaskovic-Markovic,Biljana Medjo,Marija Gavrovic-Jankulovic,Tanja Cirkovic Velickovic,Dimitrije Nikolic,Branimir Nestorovic
Pediatric Allergy and Immunology. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
38 Diclofenac sodium induced Stevens–Johnson syndrome in a hospitalized patient during treatment of splenic injury and mandibular fracture
Hideyuki Suenaga,Hideto Saijo,Kazuto Hoshi,Yoshiyuki Mori,Tsuyoshi Takato
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2013;
[Pubmed]  [Google Scholar] [DOI]
39 Dermatological manifestations and relationship to outcomes of patients admitted to a medical intensive care unit: A study from a tertiary care hospital in india
Agrawal, P. and Peter, J.V. and George, R.
Postgraduate Medical Journal. 2013; 89(1055): 501-507
[Pubmed]  [Google Scholar]
40 Characteristics of toxic epidermal necrolysis and stevens-johnson syndrome: A 5-year retrospective study
Thammakumpee, J. and Yongsiri, S.
Journal of the Medical Association of Thailand. 2013; 96(4): 399-406
[Pubmed]  [Google Scholar]
41 A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population
Patel, T.K. and Barvaliya, M.J. and Sharma, D. and Tripathi, C.
Indian Journal of Dermatology, Venereology and Leprology. 2013; 79(3): 389-398
[Pubmed]  [Google Scholar]
42 A review of cutaneous drug eruptions
Ahmed, A.M. and Pritchard, S. and Reichenberg, J.
Clinics in Geriatric Medicine. 2013; 29(2): 527-545
[Pubmed]  [Google Scholar]
43 Drug-induced rash: Nuisance or threat?
Wick, J.Y.
Consultant Pharmacist. 2013; 28(3): 160-166
[Pubmed]  [Google Scholar]
44 Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India
Naveen, K.N. and Pai, V.V. and Rai, V. and Athanikar, S.B.
Indian Journal of Pharmacology. 2013; 45(1): 80-82
[Pubmed]  [Google Scholar]
45 A clinicoetiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis
Gardezi, S.A.A. and Kazmi, A.H. and Aman, S. and Nadeem, M. and Khan, M.S. and Sohail, M.
Journal of Pakistan Association of Dermatologists. 2013; 23(1): 5-13
[Pubmed]  [Google Scholar]
46 Diclofenac-induced Stevens-Johnson syndrome: A case report
Babamahmoodi, F. and Eslami, G. and Babamahmoodi, A.
Iranian Journal of Pharmacology and Therapeutics. 2012; 11(1): 33-35
[Pubmed]  [Google Scholar]
47 An analysis of drug induced Stevens-Johnson syndrome
Pate, P.P. and Gandhi, A.M. and Desai, C.K. and Desai, M.K. and Dikshit, R.K.
Indian Journal of Medical Research. 2012; 136(6): 1051-1053
[Pubmed]  [Google Scholar]
48 Intensive Pharmacovigilance in the internal medicine ward of the Regional Hospital No.1 of the Mexican Institute of Social Security in Tijuana, B.C. [Farmacovigilancia intensiva en el servicio de medicina interna del Hospital Regional No.1 del Instituto Mexicano del Seguro Social en Tijuana, B.C.]
Salas Rojas, S.G. and Pérez Morales, M.E. and Meléndez López, S.G.
Revista Mexicana de Ciencias Farmaceuticas. 2012; 43(4): 55-68
[Pubmed]  [Google Scholar]
49 Toxic epidermal necrolysis due to lamotrigine in a pediatric patient
Barvaliya, M.J. and Patel, M.K. and Patel, T.K. and Tripathi, C.B.
Journal of Pharmacology and Pharmacotherapeutics. 2012; 3(4): 336-338
[Pubmed]  [Google Scholar]
50 Dermatologic emergencies: Rapid response by the Pharmacist
Wick, J.Y.
Pharmacy Times. 2012; 78(5)
[Pubmed]  [Google Scholar]
51 Drug-induced Stevens-Johnson syndrome: Case series from tertiary care centre in Gujarat
Bang, D. and Shah, T. and Thakker, D. and Shah, Y. and Raval, A.D.
Pharmacoepidemiology and Drug Safety. 2012; 21(4): 384-395
[Pubmed]  [Google Scholar]
52 Severe antiretroviral therapy-induced toxic epidermal necrolysis in a child
Norris, J.M. and Stuttaford, L.H. and Dowds, L.F.
Case Reports in Dermatology. 2012; 4(1): 31-36
[Pubmed]  [Google Scholar]
53
. ;
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow